Renalytix AI collaborates with AstraZeneca to develop and launch precision medicine strategies for cardiovascular, renal and metabolic diseases

  • Barbara Murphy

Press/Media

Period22 Aug 2020

Media coverage

1

Media coverage

  • TitleRenalytix AI collaborates with AstraZeneca to develop and launch precision medicine strategies for cardiovascular, renal and metabolic diseases
    Media name/outletPharmaBiz
    Country/TerritoryIndia
    Date22/08/20
    PersonsBarbara Murphy